Microcatheter for subdural hematoma treatment
Part of Brain & nervous system, Heart & circulation, Injuries & trauma clinical trials.
This trial studies a new, tiny device (microcatheter) used to block blood flow to the lining of the brain in people with a subdural hematoma (a type of blood clot on the brain). The goal is to see if this device helps stop the bleeding and reduces the need for surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You or a family member can sign a consent form.
- You have a subdural hematoma (blood clot on the brain) that is mostly old blood.
- You were able to live independently before this condition (no more than slight disability).
- You do not have an uncontrolled bleeding disorder.
- You do not have an active infection, brain tumor, or other mass in the brain.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a procedure called middle-meningeal-artery embolization, which blocks the blood supply to a chronic subdural hematoma (a slow-growing blood collection around the brain). It compares outcomes in people with one-sided versus both-sided bleeds, and aims to see if this less invasive treatment can help reduce the need for surgery or improve recovery.
This trial tests a minimally invasive procedure to treat chronic subdural hematoma (a slow bleed on the brain). It aims to stop the bleeding and reduce the risk of needing surgery.
This trial tests a procedure called middle meningeal artery embolization, which aims to stop the bleeding and reduce the fluid buildup from a chronic subdural hematoma. It may be an option for patients who have a hematoma at least 10mm thick and one or more risk factors such as older age, blood thinners, diabetes, or certain scan features.
This trial compares a newer, less invasive treatment (embolization) with traditional surgery to treat chronic subdural hematoma (a slow bleed on the brain). It aims to see which approach works better and has fewer side effects.
This trial tests whether a medicine called tranexamic acid (which helps blood clot) can help your body reabsorb a subdural hematoma, a type of bleeding on the brain, without needing surgery. If successful, this treatment could reduce the need for surgery and improve recovery.
This trial compares different materials used during a procedure to treat chronic subdural hematoma, a collection of old blood on the brain's surface. The goal is to see which material works best to prevent the blood from coming back.
Hear when a new Chronic Subdural Hematoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.